NegotiumBio and EconSight enter strategic partnership

Capturing AI-driven opportunities in pharma and life science
 
BASEL CITY, Switzerland - Oct. 23, 2023 - PRLog -- NegotiumBio (https://www.negotiumbio.com/) and EconSight (https://www.econsight.com/) announced today that the companies have entered a strategic partnership to provide AI-driven tailor-made business and technology development solutions to their customers the pharma and life science sector.

"We are delighted about working with EconSight," said Christoph Becker, Managing Partner of NegotiumBio. "Not only will this collaboration enhance the support we can provide to our clients in executing their outsourced manufacturing and business strategies, it will also enable them to think more expansively about how they can better position themselves from a capacity planning and technology investment perspective."

"Combining NegotiumBio's profound industry expertise with our groundbreaking artificial intelligence solutions creates significant value, as we together tap into new markets and capitalize on emerging opportunities," said Kai Gramke, Managing Director at EconSight. "We encourage you to stay tuned as we move forward with this exciting venture, which will help companies to be that one crucial step ahead if it comes to their investment and technology decisions."

About NegotiumBio

Supporting pharmaceutical and biotechnology innovators programs across all modalities (small and large molecules, cell and gene therapies), we provide unique direct expertise in developing targeted outsourced contract manufacturing strategies, coupled with selecting and managing the right CDMO who can meet our clients' stringent demands for speed, quality and efficiency. Learn more (https://www.negotiumbio.com/)

Contact:

Dr. Christoph Becker
inquiries@negotiumbio.com

About EconSight

An AI-driven expert in assessing and qualifying technology and industry trends based on next-generation patent analysis, EconSight identifies, analyzes, and evaluates the technological performance of companies, countries, and regions in the most important cutting-edge technologies. Learn more (https://www.econsight.com/)

Contact:

Kai Gramke
info@econsight.ch
End
Source: » Follow
Email:***@negotiumbio.com
Posted By:***@negotiumbio.com Email Verified
Tags:Artificial Intelligence
Industry:Biotech
Location:Basel City - Basel - Switzerland
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share